| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/25/2012 | EP2478099A1 Method and composition for treating alzheimer-type dementia |
| 07/25/2012 | EP2477659A1 Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same |
| 07/25/2012 | EP2477632A1 Pharmaceutical combination for treating tumor |
| 07/25/2012 | EP2477621A1 Lubiprostone for obstetrical or gynecological applications |
| 07/25/2012 | EP2077266B1 2-pyridinecarboxamide derivative having gk-activating activity |
| 07/25/2012 | EP2018170B1 Medication against breast cancer |
| 07/25/2012 | EP1372649B1 Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors |
| 07/25/2012 | EP1333808B1 Electroprocessed composition used in drug delivery and cell encapsulation |
| 07/25/2012 | EP1252162B1 Alpha v integrin receptor antagonists |
| 07/25/2012 | EP1080111B1 The induction of antiobiotic peptides by lait (scd14) protein |
| 07/25/2012 | EP0800829B2 Use of a pm-1 antibody or of a mh 166 antibody for enhancing the anti-tumor effect of cisplatin or carboplatin |
| 07/25/2012 | CN102612524A Dual variable domain immunoglobulins and uses thereof |
| 07/25/2012 | CN102612365A Checkpoint kinase 1 inhibitors for potentiating DNA damaging agents |
| 07/25/2012 | CN102612358A Stabilised particles comprising 5-methyl-(6s)-tetrahydrofolate |
| 07/25/2012 | CN102603866A Oligopeptide-based pH-sensitive amphoteric ion and application thereof in medicament |
| 07/25/2012 | CN102600472A Dosage regimen of an s1p receptor agonist |
| 07/25/2012 | CN102600455A Remedy and therapeutic method for periodontal diseases and pulpal diseases |
| 07/25/2012 | CN102600277A Medicine composition containing bacopin extracts |
| 07/25/2012 | CN102600144A Roflumilast for the treatment of diabetes mellitus |
| 07/25/2012 | CN102600082A Preparation method of tumor targeting nano-preparation |
| 07/25/2012 | CN102600073A Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method of oily preparation |
| 07/25/2012 | CN102078614B Method for inhibiting shortsightedness and application of adenylate cyclase inhibitor as medicament for inhibiting shortsightedness |
| 07/25/2012 | CN101745119B Polysaccharide conjugate of carboxylic acid drug, preparation method thereof and application thereof |
| 07/25/2012 | CN101721353B Stable thermosensitive gelatin composition |
| 07/25/2012 | CN101716219B Use of fragrant cinnamon oil in preparing medicine for burns and scalds |
| 07/25/2012 | CN101678037B Combined use of cholestanol derivative |
| 07/25/2012 | CN101259277B Novel orthopaedics medicaments carrier system and preparation thereof |
| 07/24/2012 | US8227570 Modified gherlin peptides |
| 07/24/2012 | US8227487 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 07/24/2012 | US8227474 Sodium channel blockers |
| 07/24/2012 | US8227453 Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction |
| 07/24/2012 | US8227446 Oligodeoxynucleotide and its use to induce an immune response |
| 07/24/2012 | US8227438 Suppressors of CpG oligonucleotides and methods of use |
| 07/24/2012 | US8227410 Methods of stimulating wound healing by administration of vascular endothelial growth factor D (VEGF-D) |
| 07/24/2012 | US8227243 Settings for recombinant adenoviral-based vaccines |
| 07/24/2012 | US8227200 Methods for identifying kremen polypeptide binding partners |
| 07/24/2012 | US8226972 Vaginal delivery of drugs |
| 07/24/2012 | CA2605923C Use of antagonists of oxytocin and/or vasopressin |
| 07/24/2012 | CA2490116C Acidic insulin preparations with improved stability |
| 07/24/2012 | CA2486252C Methods for screening for agents that modulate hepatocellular carcinoma development |
| 07/24/2012 | CA2477053C Composition for easing human childbirth |
| 07/24/2012 | CA2476065C Inhibitors of histone deacetylase |
| 07/24/2012 | CA2411584C Differential diagnosis of neurological diseases |
| 07/19/2012 | WO2012097054A1 Methods and compositions for treating cancer and related methods |
| 07/19/2012 | WO2012096919A1 Combination therapy of hsp90 inhibitory compounds with proteasome inhibitors |
| 07/19/2012 | WO2012095719A1 Melatonin and an antimicrobial or antibacterial agent for the treatment of acne |
| 07/19/2012 | WO2012095702A1 A composition for the regeneration of atrophic tissues |
| 07/19/2012 | WO2012095505A1 Anticancer therapy with dual aurora kinase / mek inhibitors |
| 07/19/2012 | WO2012094744A1 Prognostic signature for oral squamous cell carcinoma |
| 07/19/2012 | WO2012069658A3 Immunomodulatory compositions comprising hydralazine for the treatment gastrointestinal disorders |
| 07/19/2012 | US20120184601 Antiviral oligonucleotides |
| 07/19/2012 | US20120184551 Combination of brimonidine and timolol for topical ophthalmic use |
| 07/19/2012 | US20120183579 Compounds for inflammation and immune-related uses |
| 07/19/2012 | US20120183544 Diagnosis and treatment of neuroectodermal tumors |
| 07/19/2012 | CA2824480A1 Anticancer therapy with dual aurora kinase / mek inhibitors |
| 07/18/2012 | EP2476667A2 Aminoheteroaryl compounds as protein kinase inhibitors |
| 07/18/2012 | EP2476438A1 Medicament including antibody composition specifically bound to human cc chemokine receptor 4 (ccr4) |
| 07/18/2012 | EP2475430A1 Granulated anthelmintic preparations and delivery systems |
| 07/18/2012 | EP2101763B1 Pharmaceutical compositions and their methods of use |
| 07/18/2012 | EP1720554B1 Use of meloxicam for the treatment of respiratory diseases in pigs |
| 07/18/2012 | EP1542701B1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 07/18/2012 | EP1437961B1 Methods of suppressing microglial activation |
| 07/18/2012 | CN1917890B Composition and method for use in cartilage affecting conditions |
| 07/18/2012 | CN1794983B Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 07/18/2012 | CN1738636B Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states |
| 07/18/2012 | CN1449445B Ev-vegf nucleic acids and polypeptides and methods of use |
| 07/18/2012 | CN102597779A Method for determination of sensitivity to anti-cancer ag |
| 07/18/2012 | CN102597778A Method for determination of sensitivity to anti-cancer ag |
| 07/18/2012 | CN102597762A Anticancer agent sensitivity-determining marker |
| 07/18/2012 | CN102597235A Lung and esophageal cancer related gene ADAMTS18 |
| 07/18/2012 | CN102596202A New crystalline form of pemirolast |
| 07/18/2012 | CN102596194A Combination medicament |
| 07/18/2012 | CN102585258A Gelatin embolism microsphere and preparation method and application thereof |
| 07/18/2012 | CN102585036A Amphiphilic chitosan derivative, its preparation method and its application in medicinal preparation |
| 07/18/2012 | CN102580108A Novel oily liquid auxiliary material for soft capsules for reducing blood fat |
| 07/18/2012 | CN102580099A Composition for resisting ischemia reperfusion injury and preparation method and application thereof |
| 07/18/2012 | CN102580098A Reagent for exciting salivary secretion |
| 07/18/2012 | CN102580097A Medicinal composition containing azilsartan |
| 07/18/2012 | CN102580096A Sodium sulfadiazine compound preparation for treating pig brain hydropsy, and preparation method and application thereof |
| 07/18/2012 | CN102580095A Pharmaceutical composition containing angiotensin II receptor antagonist |
| 07/18/2012 | CN102580094A Medicine for treating fowl plague and duck plague |
| 07/18/2012 | CN102580093A Injection for preventing piglet diseases and preparation method thereof |
| 07/18/2012 | CN102580092A Regulation of ferroportin and application thereof |
| 07/18/2012 | CN102580091A Method for enhancing analgesic action of opioid analgesic and reagent |
| 07/18/2012 | CN102580090A Granule for treating hypertension |
| 07/18/2012 | CN102579507A Natto-derived lipase inhibitor and preparation method and application thereof |
| 07/18/2012 | CN102579387A Pharmaceutical compositions comprising an S1P modulator |
| 07/18/2012 | CN102579376A Non-steroidal anti-inflammatory drug orally disintegrating tablet and producing method thereof |
| 07/18/2012 | CN102579375A Lipid lowering medicament orally disintegrating tablets and preparation method thereof |
| 07/18/2012 | CN102579334A Nasal drops containing sodium hyaluronate and preparation method thereof |
| 07/18/2012 | CN102038953B Composite for local anesthesia before ophthalmologic operation and preparation method and application thereof |
| 07/18/2012 | CN101880283B Azaindole kinase inhibitors |
| 07/18/2012 | CN101715349B Therapeutic compositions and methods for treating gram-negative bacterial infections |
| 07/18/2012 | CN101711862B Medicine target spot relevant to inflammatory diseases and application thereof |
| 07/18/2012 | CN101678029B Combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders |
| 07/18/2012 | CN101646436B Use of antagonists of oxytocin and/or vasopressin in assisted reproductive technology |
| 07/18/2012 | CN101370488B Compositions for increasing insulin sensitivity |
| 07/18/2012 | CN101137358B Antiviral compositions and methods of use |
| 07/17/2012 | US8224438 Method for directed intranasal administration of a composition |
| 07/17/2012 | US8222398 Chimeric immunomodulatory compounds and methods of using the same-II |